Kalkstein Robert L 4
4 · CONVERSION LABS, INC. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Kalkstein Robert L
Chief Financial Officer
Transactions
- Other
Options to purchase Common Stock
2017-10-01$0.28/sh+150,000$42,000→ 150,000 totalExercise: $0.28From: 2017-10-01Exp: 2027-09-30→ Common Stock (150,000 underlying) - Other
Options to purchase Common Stock
2019-03-01$0.28/sh+150,000$42,000→ 150,000 totalExercise: $0.28From: 2019-03-31Exp: 2027-09-30→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]These options were previously reported by Mr. Kalkstein on his Form 3 filed with the Commission on November 13, 2017. Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28.
- [F2]Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28 and now vest on March 31, 2019. Additionally, the 200,000 to be issued to Mr. Kalkstein pursuant to his consulting agreement were cancelled and Mr. Kalkstein also has forgone $32,500 owed to him by Conversion Labs, Inc.